Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thrombosis incidence after limb salvage surgery with rivaroxaban versus standard treatment
RBR-6mctrm2Phase 4Recruiting
- Sponsor
- Hospital das Clínicas da UFPE
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban, aspirin, clopidogrel in chronic limb-threatening ischemia (CLTI), deep vein thrombosis (DVT), sponsored by Hospital das Clínicas da UFPE. Started Mar 2024; status: recruiting.
02
Drugs
rivaroxabanaspirinclopidogrel
03
Conditions
chronic limb-threatening ischemia (CLTI)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on RBR-6mctrm2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6mctrm2.